MI, U.S.A.), sodium hydroxide (Fisher Scientific, Fairlawn, NJ, U.S.A.), verapamil hydrochloride (Knoll Pharmaceuticals, Whippany, NJ, U.S.A.), and l-(diethylaminoethyl)-~(p-ethoxybenzyl)-5nitrobenzimidazole.
HCI, the internal standard, were used.
Stock solutions
Verapamil stock solution. Verapamil l HCl (10.0 mg) was dissolved in 100 ml methanol to yield a stock solution containing 100 pg/ml verapamil l HCl.
Internal standard stock solution. Internal standard (25.0 mg) was dissolved in 25 ml ethyl acetate to yield a stock solution containing 1.0 mg/ml internal standard.
Standards
Verapamil standard solution. The verapamil stock solution was diluted 1:5 to yield a 20 pg/ml verapamil l HCl standard solution.
Internal standard solution. The internal standard stock solution (50 ~1) was diluted to 5 ml to yield a 10 pg/ml internal standard solution.
Quality-control samples
To a 25-ml volumetric flask, 750 ~1 of the verapamil standard solution (20 pg/ml) were added and the final volume adjusted to 25 ml by addition of blank plasma. After mixing, 1.25-ml aliquots were transferred to glass tubes, tightly capped and stored frozen at -20" C until use. Each quality-control sample contained 600 ng/ml verapamil. Of the sample 1 ml was used for analysis.
Chromatographic conditions
The gas chromatograph (Varian Model 3700) was equipped with a thermionic specific detector and a deactivated, silylated glass column (1.2 m X 2 mm I.D., 6 mm O.D.) packed with 1% OV-1 on 60-80 mesh Gas-Chrom Q. The carrier gas was pre-purified nitrogen set to a flow-rate of 30 ml/min. The air flow-rate to the detector was adjusted to 175 ml/min and the hydrogen flow-rate was set to 4.5 ml/min. The bead current and bias voltage settings were 470 and 4, respectively. The electrometer attenuation was set at 2-8 * lo-". The gas chromatograph operating conditions were: injector temperature, 28O"C, column temperature, 25O"C, and the detector temperature, 280°C. The column was conditioned at 270°C for 24 h.
Sample preparation
To glass tubes (15 ml capacity) were added 1 ml plasma, 50 ~1 internal standard solution, 50 ~1 sodium hydroxide (10 M) and 7.5 ml pentane-diethyl ether (70:30). The tubes were tightly capped and shaken for 15 min. The tubes were then centrifuged at 1000 g for 10 min (room temperature) and 6.0 ml of the organic phase (upper layer) were transferred to clean glass tubes and evaporated to dryness at 40°C with a stream of air. The residue was then reconstituted in 100 ~1 ethyl acetate and 2.0 ~1 were injected for GLC analysis.
RESULTS AND DISCUSSION
Typical chromatograms of a calibration standard (100 ng/ml verapamil), a pre-dose (blank) sample from an experimental subject (dog), and a plasma sample obtained from that subject after the intravenous (i.v.) administration of verapamil are shown in Fig. 1 The calibration curve was found to be linear over the verapamil concentration range of 50--1000 ng/ml. The best-fit least-squares line was obtained by using a calibration curve program on the Apple II plus microcomputer.
The data best fit a straight line. The correlation coefficients for inter-day standard calibration curves ranged from 0.9955 to 0.9989. The coefficients of variation (C.V., %) calculated from the inversely estimated concentrations for inter-day standard calibration curves ranged from 4.87% to 6.82%. The intra-day reproducibility of the calibration samples had C.V. values ranging from 1.11% to 9.31% as shown in Table I . The accuracy of the method was assessed by analyzing quality-control samples on each assay day. The quality-control sample variability was found to have a C.V. of 9.26% and a mean concentration of 592.7 ng/ml with the theoretical concentration being 600 ng/ml.
Application of the method developed was demonstrated by measuring plasma levels of verapamil in dogs after a short i.v. infusion of verapamil. The plasma concentration-time profile of verapamil obtained in one such pharmacokinetic study is shown in Fig. 2 . The post-infusion data are well described by the following polyexponential equation:
The distribution half-life (tl/aa) of verapamil was 4.4 min and the terminal halflife (tsp) was 39 min. Several analytical methods for verapamil determination require multiple extraction steps [5] [6] [7] 9 , 101 and are, therefore, time-consuming. The HPLC procedures described in the literature [5, 6, require longer chromatographic separation time as compared to the GLC method reported here. Several HPLC methods allow the determination of verapamil and some of its metabolites. However, only norverapamil has been shown to possess some biological activity. Although this method has not been applied for the determination of verapamil levels in clinical studies involving humans, the calibration samples and assay validation studies utilized both human and dog blank (control) plasmas interchangeably, and no interfering peaks were seen. The authors will be using this procedure for the determination of verapamil levels in plasma samples from a controlled clinical trial. Also, the sensitivity, precision and accuracy of this procedure compares well with those reported in the literature.
